PubMed HealthSearch

PubMed · 6943821

Lowe's syndrome.

Abstract

The histopathological manifestations in four eyes from two male patients with the oculo-cerebro-renal syndrome of Lowe included a small, discoid, cataractous lens, peculiar capsular and epithelial changes with aberrant formation of collagenous fibrous tissue, polar lenticular changes with anterior vitreous condensation, embryonic anterior chamber angle with anterior displacement of rudimentary ciliary processes, segmental hypoplasia of iris dilator muscle, and Lange's folds with peripheral retinal cystoid changes. Additional findings in one of the cases included bilateral corneal keloids, vitreous organization, hyalinized retinal vessels, and mild gliosis. We suggest that the congenital ocular abnormalities in Lowe's syndrome are related to an as yet unidentified, inherited enzymatic and/or biochemical defect, and that they progress further because of an abnormal aqueous humour environment. The role of aminoaciduria and mucopolysaccharidosis in the pathogenesis of systemic and ocular defects is discussed in the light of recent investigations.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

R C Tripathi, G W Cibis, B J Tripathi. 1980. Lowe's syndrome.. https://pubmed.ncbi.nlm.nih.gov/6943821/

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

Performing peripheral iridectomy via a scleral tunnel incision: a new approach.

A peripheral iridectomy (PI) is sometimes difficult to perform through a sclero-corneal tunnel. This study evaluated the effectiveness and safety of a newly proposed technique for performing a PI. The results showed that a PI can be easily performed through a sclero-corneal tunnel, employing this technique.

Anterior Chamber

Intraocular levels of methotrexate after intravenous administration.

PURPOSE: To determine if adequate intraocular levels of methotrexate are achieved after intravenous administration. METHODS: After intravenous administration, methotrexate levels were determined in the serum, the anterior chamber, and the cerebrospinal fluids of a patient with recurrent ocular lymphoma. A fluorescence polarization immunoassay was used to make the determinations. RESULTS: At seven hours into a 24-hour intravenous infusion, methotrexate was at cytotoxic level in all samples. At 74 hours, cytotoxic levels were present only in the aqueous humor. CONCLUSION: Sustained cytotoxic ocular methotrexate levels are achievable after systemic administration.

Anterior Chamber